Floatz logo

14 assets in Colonic Neoplasm

Therapeutic assets addressing Colonic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Oxaliplatin
Colonic Neoplasm
First Affiliated Hospital of Guangxi Medical UniversityP4BB (70)
Capecitabine
Colonic Neoplasm
First Affiliated Hospital of Guangxi Medical UniversityP3B (63)
Fentanyl
Colonic Neoplasm
RenJi HospitalP4B (62)
Tislelizumab
Colonic Neoplasm
First Affiliated Hospital of Guangxi Medical UniversityP3B (62)
Dostarlimab
Colonic Neoplasm
GlaxoSmithKlineP3B (60)
Atezolizumab
Colonic Neoplasm
Gritstone bio, Inc.P2B (57)
Grt-C901
Colonic Neoplasm
Gritstone bio, Inc.P2CCC (53)
Grt-R902
Colonic Neoplasm
Gritstone bio, Inc.P2CCC (53)
Ipilimumab
Colonic Neoplasm
Gritstone bio, Inc.P2CCC (53)
Cyclophosphamide
Colonic Neoplasm
National Cancer Institute (NCI)P1CC (41)
Fludarabine
Colonic Neoplasm
National Cancer Institute (NCI)P1CC (41)
Tnhyp217 Car T Cells
Colonic Neoplasm
National Cancer Institute (NCI)P1CC (41)
Lactulose
Colonic Neoplasm
Zhang Xiaofeng,MDN/AD (30)
Macrogols
Colonic Neoplasm
Zhang Xiaofeng,MDN/AD (30)